AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report

AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

AstraZeneca PLC (AstraZeneca or 'the company') is global biopharmaceutical company involved in developing, manufacturing and marketing prescription pharmaceuticals. The company provides drugs for three therapeutic areas including oncology, cardiovascular and metabolic disease (CVMD) and respiratory, while selectively pursuing therapies in autoimmunity, infection and neuroscience. The company has three strategic R&D centers located in Gaithersburg, the US; Gothenburg, Sweden; and Cambridge, the UK. Major brandsof the company include Faslodex, Zoladex, Tagrisso, Iressa,Symbicort, Pulmicort, Lynparza, Nexium, and Onglyza. The company has its operations in the Americas, Europe and Asia. The company has its headquarter in London, the UK.

Scope

– Detailed information on AstraZeneca PLC required for business and competitor intelligence needs

– A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis

– An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments

– Intelligence on AstraZeneca PLC's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on AstraZeneca PLC's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

AstraZeneca PLC: Company Overview

AstraZeneca PLC: Overview and Key Facts

AstraZeneca PLC: Overview

AstraZeneca PLC: Key Facts

AstraZeneca PLC: Key Employees

AstraZeneca PLC: Key Employee Biographies

AstraZeneca PLC: Major Products and Services

AstraZeneca PLC: Company History

AstraZeneca PLC: Management Statement

AstraZeneca PLC: Locations and Subsidiaries

AstraZeneca PLC: Key Competitors

AstraZeneca PLC: Company Analysis

AstraZeneca PLC: Business Description

AstraZeneca PLC: SWOT Analysis

AstraZeneca PLC: SWOT Overview

AstraZeneca PLC: Strengths

AstraZeneca PLC: Weaknesses

AstraZeneca PLC: Opportunities

AstraZeneca PLC: Threats

AstraZeneca PLC: Corporate Financial Deals Activity

AstraZeneca PLC: Financial Deals Overview

AstraZeneca PLC: Targets and Partners

AstraZeneca PLC: Top Deals 2015 - 2019YTD*

AstraZeneca PLC: Advisors

AstraZeneca PLC: Top Legal Advisors

AstraZeneca PLC: Top Financial Advisors

AstraZeneca PLC: Mergers and Acquisitions

AstraZeneca PLC: Corporate Venturing

AstraZeneca PLC: Capital Raising

AstraZeneca PLC: Partnership

AstraZeneca PLC: Divestments

AstraZeneca PLC: Recent Developments

AstraZeneca PLC: News and Events Summary

AstraZeneca PLC: Business Expansion

AstraZeneca PLC: Contracts

AstraZeneca PLC: Corporate Governance

AstraZeneca PLC: Corporate Social Responsibility

AstraZeneca PLC: Financial Deals

AstraZeneca PLC: Market Developments

AstraZeneca PLC: Regulatory and Legal Events

AstraZeneca PLC: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: AstraZeneca PLC: Key Facts

Table 2: AstraZeneca PLC: Key Employees

Table 3: AstraZeneca PLC: Company History

Table 4: AstraZeneca PLC: Locations and Subsidiaries

Table 5: AstraZeneca PLC: Key Competitors

Table 6: AstraZeneca PLC: Deal Activity by Deal Type – Volume (TTM*)

Table 7: AstraZeneca PLC: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Table 8: AstraZeneca PLC: M&A Average Deal Size – Value (US$m)

Table 9: AstraZeneca PLC: Targets and Partners

Table 10: AstraZeneca PLC: Top Deals 2015 – 2019YTD*

Table 11: AstraZeneca PLC: Legal Advisor Ranking by Value (US$m)

Table 12: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)

Table 13: AstraZeneca PLC: M&A Volume and Value Trend (2015 – YTD*2019)

Table 14: AstraZeneca PLC: M&A Activity by Geography (2015 – YTD*2019)

Table 15: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Table 16: AstraZeneca PLC: Corporate Venturing by Geography (2015 – YTD*2019)

Table 17: AstraZeneca PLC: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Table 18: AstraZeneca PLC: Capital Raising by Deal Type (2015 – YTD*2019)

Table 19: AstraZeneca PLC: Partnership Volume and Value Trend (2015 – YTD*2019)

Table 20: AstraZeneca PLC: Partnership Trend by Deal Type (2015 – YTD*2019)

Table 21: AstraZeneca PLC: Divestments Volume and Value Trend (2015 – YTD*2019)

Table 22: AstraZeneca PLC: Divestments by Geography (2015 – YTD*2019)

Table 23: AstraZeneca PLC: News and Events Summary

Table 24: AstraZeneca PLC: Business Expansion

Table 25: AstraZeneca PLC: Contracts

Table 26: AstraZeneca PLC: Corporate Governance

Table 27: AstraZeneca PLC: Corporate Social Responsibility

Table 28: AstraZeneca PLC: Financial Deals

Table 29: AstraZeneca PLC: Market Developments

Table 30: AstraZeneca PLC: Regulatory and Legal Events

Table 31: AstraZeneca PLC: Strategy and Operations

List of Figures

List of Figures

Figure 1: AstraZeneca PLC: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: AstraZeneca PLC: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Figure 3: AstraZeneca PLC: M&A Average Deal Size – Value (US$m)

Figure 4: AstraZeneca PLC: M&A Volume and Value Trend (2015 – YTD*2019)

Figure 5: AstraZeneca PLC: M&A Activity by Geography (2015 – YTD*2019)

Figure 6: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Figure 7: AstraZeneca PLC: Corporate Venturing by Geography (2015 – YTD*2019)

Figure 8: AstraZeneca PLC: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Figure 9: AstraZeneca PLC: Capital Raising by Deal Type (2015 – YTD*2019)

Figure 10: AstraZeneca PLC: Partnership Volume and Value Trend (2015 – YTD*2019)

Figure 11: AstraZeneca PLC: Partnership Trend by Deal Type (2015 – YTD*2019)

Figure 12: AstraZeneca PLC: Divestments Volume and Value Trend (2015 – YTD*2019)

Figure 13: AstraZeneca PLC: Divestments by Geography (2015 – YTD*2019)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports